AngioDynamics names Eric Honroth CEO effective November 2, 2026
AngioDynamics said Eric Honroth will become President and Chief Executive Officer and a director effective November 2, 2026, succeeding James Clemmer, who has led the company since April 2016 and is retiring. The filing also sets Honroth's pay, including a $735,000 base salary and a $350,000 sign-on bonus, and a $30,000 monthly consulting arrangement for Clemmer for one year.
Key points
- Eric Honroth, 55, most recently served as President Life Science at Getinge AB from 2018 to 2026.
- Honroth's base salary is $735,000, with a target annual bonus of 95% of base salary.
- Honroth receives a $350,000 cash sign-on bonus, repayable if he leaves without Good Reason or is terminated for Cause within the first year.
- Clemmer will consult for the company for one year at $30,000 per month; Howard Donnelly plans to retire as a Class II director at the end of his current term.
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 08, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.